Skip to main content
SpringerLink
Log in
Book cover

Prostate Cancer pp 101–112Cite as

Preoperative Imaging Techniques in Prostate Cancer

  • Chapter

  • 131 Accesses

Abstract

Prostate cancer now outnumbers lung cancer as the most common cancer in American men. Nearly 200,000 new cases are seen yearly, and prostate cancer is the cause of 31,000 deaths each year. A significant migration to prostate-confined disease has taken place in recent years, but 40%–60% of those with this cancer are still found to have extracapsular disease after radical prostatectomy [74]. Although the intent and hope of such surgery has been cure, overall survival of roughly half of them may be limited. Prostate cancer can vary widely in its aggressiveness. Some men die of prostate cancer, but most still die with rather than of their cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarnink RG, Beerlage HP, de la Rosette J.J.M.C.H, et al (1998) Transrectal ultrasound of the prostate: innovations and future applications. J Urol 159:1568–1579

    Article  PubMed  CAS  Google Scholar 

  2. Altman AL, Resnick MD. (2001) Ultrasonographically guided biopsy of the prostate. J Ultrasound Med 20:159–167

    PubMed  CAS  Google Scholar 

  3. American Urological Association (AUA) (2000) Prostate-specific antigen (PSA) best practice policy. Oncology (Huntingt) 14:267–286

    Google Scholar 

  4. Babaian RJ, Sayer J, Podoloff DA, et al (1994) Radioimmunoscintigraphy of pelvic lymph nodes with 111-indium-labeled monoclonal antibody CYT-356. J Urol 152:1952–1955

    PubMed  CAS  Google Scholar 

  5. Bezzi M, Kressel HY, Allen KS, et al (1998) Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 169:339–346

    Google Scholar 

  6. Biondetti PR, Lee J.K.T, Ling D, et al (1987) Clinical stage B prostate carcinoma: staging with MR imaging. Radiology 162:325–329

    PubMed  CAS  Google Scholar 

  7. Bryant LH. Jr, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA. (1999) Synthesis and relaxometry of high-generation (G=5,7,9 and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 9:348–352

    Article  PubMed  Google Scholar 

  8. Catalona WJ (1995) Surgical management of prostate cancer. Cancer 75:1903-1906

    Google Scholar 

  9. Chelsky MJ, Schnall MD, Seidmon EJ, et al (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391–395

    PubMed  CAS  Google Scholar 

  10. Cher ML, Bianco FJ, Lam JS, et al (1998) Limited role of radionucleotide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160:1387–1391

    Article  PubMed  CAS  Google Scholar 

  11. Chodak GW, Keller P, Schoenberg HW. (1989) Assessment of screening for prostate cancer using the digital rectal examination. J Urol 141:1136–1138

    PubMed  CAS  Google Scholar 

  12. Chybowski FM, Keller JJ, Bergstrahl EJ, et al (1991) Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 145:313

    PubMed  CAS  Google Scholar 

  13. Conrad S, Graefen M, Pichlmeier U, et al (1998) Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 159:2023–2029

    Article  PubMed  CAS  Google Scholar 

  14. Cooner WH. (1992) Rectal examination and ultrasonography in the diagnosis of prostate cancer. Prostate Suppl 4:3–10

    Article  PubMed  CAS  Google Scholar 

  15. Cooner WH, Mosley BR, Rutherford CL. Jr, et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146–1152

    PubMed  CAS  Google Scholar 

  16. Costello LC, Franklin RB, Narayan P (1999) Citrate in the diagnosis of prostate cancer. Prostate 38:237–245

    Article  PubMed  CAS  Google Scholar 

  17. Crawford ED, Batuello JT, Snow P, et al (2000) The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma. Cancer 88: 2105–2109

    Article  PubMed  CAS  Google Scholar 

  18. D’Amico AV, Whittington R, Malkowicz SB, et al (1994) A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biophys 30:293–302

    Article  Google Scholar 

  19. D’Amico AV, Whittington R, Malkowicz SB, et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy of interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974

    Article  PubMed  Google Scholar 

  20. D’Amico AV, Schnall M, Whittington R, et al (1998) Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 51:449-454

    Google Scholar 

  21. Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Borkowski A, Schulman C, Marberger M (2001) Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 166:856–860

    Article  PubMed  CAS  Google Scholar 

  22. Dresner MA, Rose GH, Rossmann PJ, et al (1998) Magnetic resonance elastography of the prostate [abstract]. Radiology 209:181

    Google Scholar 

  23. Eastham JA, Scardino PT. (2000) Radical prostatectomy for clinical stage Ti and T2 prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU., et al (eds) Comprehensive textbook of genitourinary oncology, 2nd ed. Lippincott Williams & Wilkins, Baltimore, pp 722–728

    Google Scholar 

  24. Flanigan RC, McKay TC, Olson M, et al (1996) Limited efficacy of preoperative computed tomography scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48:428–432

    Article  PubMed  CAS  Google Scholar 

  25. Forsberg F, Merton DA, Liu JB, et al (1998) Clinical applications of ultrasound contrast agents. Ultrasonics 36:695–701

    Article  PubMed  CAS  Google Scholar 

  26. Frazier HA, Robertson JE, Paulson DF. (1994) Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol 12:308–312

    Article  PubMed  Google Scholar 

  27. Gann PH, Hennekens CH, Stampfer MJ. (1995) A prospective evaluation of plasma prostatespecific antigen for detection of prostatic cancer. JAMA 273:289–294

    Article  PubMed  CAS  Google Scholar 

  28. Golimbu M, Morales P, Al-Askari S, et al (1979) Extended lymphadenectomy for prostatic cancer. J Urol 121:617–620 Another copyeditor has arranged the list alphabetically

    PubMed  CAS  Google Scholar 

  29. Goto Y, Ohori M, Arakawa A, et al (1996) Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156:1059–1063

    Article  PubMed  CAS  Google Scholar 

  30. Hahn P, Smith I.C.P, Leboldus L, et al (1997) The classification of benign and malignant human prostate tissue by multivariate analysis of H-I magnetic resonance spectra. Cancer Res 57: 3398–3401

    PubMed  CAS  Google Scholar 

  31. Halpern D.J, Verkh I, Fosberg F, et al (2000) Initial experience with contrast enhanced sonography of the prostate. AJR Am J Roentgenol 174:1575–1580

    Article  PubMed  CAS  Google Scholar 

  32. Hara T, Kosaka N, Kishi H (1998) PET imaging of prostate cancer using carbon-11 choline. J Nucl Med 39:990–995

    PubMed  CAS  Google Scholar 

  33. Harisinghani MG, Saini S, Weissleder R, et al (1999) MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 172:1347–1351

    Article  PubMed  CAS  Google Scholar 

  34. Hebden JC, Arridge SR, Delpy DT. (1997) Optical imaging in medicine. I. Experimental techniques. Phys Med Biol 42:825–840

    Article  PubMed  CAS  Google Scholar 

  35. Hofmann R, Heidenreich A, Engelmann U (2000) Radical pelvic lymphadenectomy in clinically localized prostate cancer: high frequency of atypical metastases. J Urol 163:294

    Google Scholar 

  36. Hricak H, Doms GC, Jeffrey RB, et al (1987) Prostate carcinoma: staging by clinical assessment, CT, and MRI. Radiology 162:331–336

    PubMed  CAS  Google Scholar 

  37. Huncharek M, Muscat J (1996) Serum prostate specific antigen as a predictor of staging abdominal/ pelvic computed tomography in newly diagnosed prostate cancer. Abdom Imaging 21:364–367

    Article  PubMed  CAS  Google Scholar 

  38. Husband JE, Padhani AR, Mac Vicar DA, et al (1998) Magnetic resonance imaging of prostate cancer: comparison of image quality using endorectal and pelvic phased array coils. Clin Radiol 53:673–681

    Article  PubMed  CAS  Google Scholar 

  39. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al (1995) Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 274:1445–1449

    Article  PubMed  CAS  Google Scholar 

  40. Jager GJ, Ruijter E.T.G, vander Kaa CA, et al (1997) Dynamic turboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 204:645–652

    Google Scholar 

  41. Jager GJ, Severns JL, Thornbury JR, et al (2000) Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 215:445–451

    PubMed  CAS  Google Scholar 

  42. Johnstone P.A.S, Tarman G, Riffenburgh R, et al (1997) Yield of imaging and scintigraphy assessing bNED failure in prostate cancer patients. Urol Oncol 3:108–112

    Article  PubMed  CAS  Google Scholar 

  43. Kahn D, Williams RD, Manyak MJ, et al (1998) 111-Indium capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group. J Urol 159:2041; discussion 2046-2047

    Article  PubMed  CAS  Google Scholar 

  44. Kahn D, Williams RD, Haseman MK,et al (1998) Radioimmunoscintigraphy with In-111 labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. J Clin Oncol 16:284–289

    PubMed  CAS  Google Scholar 

  45. Kane DJ, Amling CL, Johnstone P.A.S, et al (1999) Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy [abstract no. 667]. J Urol 161 [Suppl]:176

    Article  Google Scholar 

  46. Kane RD, Paulson DF. (1977) Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostate adenocarcinoma. J Urol 117:618–621

    PubMed  CAS  Google Scholar 

  47. Kattan MW, Cowen ME, Miles BJ. (1997) A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 12:299–305

    Article  PubMed  CAS  Google Scholar 

  48. Kattan MW, Beck JR, Miles BJ. (2000) Quantitative approaches to diagnostic testing and decision making in genitourinary oncology. In: Vogelzang NJ, Scardino PT, Shipley WU, et al (eds) Comprehensive textbook of genitourinary oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 22–30

    Google Scholar 

  49. Kramer S, Gorich J, Gottfried HW, et al (1997) Sensitivity of computed tomography in detecting local recurrence of prostate carcinoma following radical prostatectomy. Br J Radiol 70:995–999

    PubMed  CAS  Google Scholar 

  50. Kuppusamy P, Chzan M, Vij K, et al (1994) Three-dimensional spectral spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolims and oxygenation. Proc Natl Acad Sci USA 91:3388–3392

    Article  PubMed  CAS  Google Scholar 

  51. Landis SH, Murray T, Bolden S, et al (1999) Cancer statistics. Cancer J Clin 49:8–31

    Article  CAS  Google Scholar 

  52. Lee F, Gray JM, McLeary RD, et al (1985) Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology and staging. Prostate 7:117–129

    Article  PubMed  CAS  Google Scholar 

  53. Lee N, Newhouse JH, Olsson CA, et al (1999) Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 599 patients. Urology 54:490–494

    Article  PubMed  CAS  Google Scholar 

  54. Manyak MJ, Javitt MC. (1998) The role of computerized tomography magnetic resonance imaging, bone scan and monoclonal antibody nuclear scan for prognosis prediction in prostate cancer. Semin Urol Oncol 16:145–152

    PubMed  CAS  Google Scholar 

  55. May P, Truemann T, Dettmar P, et al (2001) Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in a staging of clinically localized prostatic cancer. BJU Int 1:66–69

    Article  Google Scholar 

  56. Messing E, Manola J, Sarosdy M, et al (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer. New Engl J Med 341:1781–1788

    Article  PubMed  CAS  Google Scholar 

  57. Moul JW, Kane J, Malkowicz S (2001) The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. Urol Clin North Am 28:459–472

    Article  PubMed  CAS  Google Scholar 

  58. Nakashima J, Imai Y, Tachibana M, et al (1997) Effects of endocrine therapy on the primary lesion in patients with prostate carcinoma as evaluated by endorectal magnetic resonance imaging. Cancer 80:237–241

    Article  PubMed  CAS  Google Scholar 

  59. Noldus J, Graefen M, Huland E, et al (1998) The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer. J Urol 159:2004–2007

    Article  PubMed  CAS  Google Scholar 

  60. Oesterling JE. (1995) Using prostate specific antigen to eliminate unnecessary diagnostic tests: significant worldwide economic implications. Urology 46 [Suppl 3A]:26–33

    Article  PubMed  CAS  Google Scholar 

  61. Oesterling JE, Martin SK, Bergstrahl EJ, et al (1993) The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269:57–60

    Article  PubMed  CAS  Google Scholar 

  62. Ohori M, Egawa S, Shinohara K, et al (1994) Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. Br J Urol 74:72–79

    Article  PubMed  CAS  Google Scholar 

  63. Ophir J, Garni B, Kallel F, et al (2000) Elastography imaging. Ultrasound Med Biol 26 [Suppl]:23–29

    Article  Google Scholar 

  64. Padbani AR, Gapinski CJ, MacVicar DA, et al (2000) Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99–109

    Article  Google Scholar 

  65. Pannek J, Subong EN, Jones KA, et al (1996) The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology 48:51–54

    Article  PubMed  CAS  Google Scholar 

  66. Partin AW, Kattan MW, Subong EN, et al (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update [see comments] (published erratum appears in JAMA (1997) 278:118). JAMA 277:1445–1451

    Article  PubMed  CAS  Google Scholar 

  67. Partin AW, Yoo J, Carter HB, et al (1999) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150: 110–114

    Google Scholar 

  68. Perotti M, Kaufman RP, Jennings TA, et al (1996) Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 156:106–109

    Article  Google Scholar 

  69. Piatt JF, Bree RI, Schwab RE. (1987) accuracy of CT in the staging of carcinoma of the prostate. AJR Am J Roentgenol 149:315–318

    Article  Google Scholar 

  70. Pollack HM, Banner MP. (1994) Diagnostic uroradiology. In: Hanno PM, Wein AJ. (eds) Clinical manual of urology, 2nd edn. McGraw Hill, New York, pp 89–136

    Google Scholar 

  71. Pound CR, Partin AW, Epstein JI, et al (1997) Prostate-specific antigen after anatomic retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24:395–406

    Article  PubMed  CAS  Google Scholar 

  72. Pound CR, Partin AW, Eisenberger MA, et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591–1597

    Article  PubMed  CAS  Google Scholar 

  73. Reitbergen J.B.W, Hoedemaeker RF, Boeken Kruger AE, et al (1999) The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol 161:1192–1198

    Article  Google Scholar 

  74. PT, Weaver R, Hudson MA (1992) Early detection of prostate cancer. Hum Pathol 23:211–222

    Article  PubMed  Google Scholar 

  75. Scheidler J, Hricak H, Vigneron DB, et al (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging: clinicopathologic study. Radiology 213:473–480

    PubMed  CAS  Google Scholar 

  76. Scher HI, Heller (2000) Clinical states in prostate cancer: toward a dynamic model of disease progression. Urology 55:323–327

    Article  PubMed  CAS  Google Scholar 

  77. Scher HI, Isaacs JT, Zelefsky MJ, et al (2000) Prostate cancer. In: Abeloff MD, Armitage JO, Lichter AS,et al (eds) Clinical oncology, 2nd edn. Churchill Livingstone, New York, pp 1823–1835

    Google Scholar 

  78. Schiebler ML, Schnall MD, Pollack HM, et al (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339–352

    PubMed  CAS  Google Scholar 

  79. Schnall MD, Imai Y, Tomaszewski JE, et al (1991) Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 178:797–802

    PubMed  CAS  Google Scholar 

  80. Schnall MD, Connick T, Hayes CE, et al (1992) MR imaging of the pelvis with an endorectal-external multicoil array. J Magn Reson Imaging 2:229–232

    Article  PubMed  CAS  Google Scholar 

  81. Seltzer MA, Barbaric Z, Belldegrun A, et al (1999) Comparison of helical computed tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol 162:1322–1328

    Article  PubMed  CAS  Google Scholar 

  82. Shinohara K, Wheeler TM, Scardino PT. (1989) The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142:76–82

    PubMed  CAS  Google Scholar 

  83. Soloway MS, Obek C (2000) Periprostatic local anaesthetic before ultrasound guided prostatic biopsy. J Urol 163:172–173

    Article  PubMed  CAS  Google Scholar 

  84. Southwick PC, Catalona WJ, Partin AW, et al (1999) Prediction of post-radical prostatectomy pathological outcome for stage Tic prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial. J Urol 162:1346–1351

    Article  PubMed  CAS  Google Scholar 

  85. Stamey TA, Yang N, Hay AR, et al (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916

    Article  PubMed  CAS  Google Scholar 

  86. Stanford JL, Stephenson RA, Coyle LM, et al (1999) Prostate Cancer trends 1973-1995, NIH Pub. No. 99-4543 edn. SEER Program. National Cancer Institute, Bethesda

    Google Scholar 

  87. Svatec D, Thompson IM. (1998) PSA screening-current controversy. Ann Oncol 9:1283–1288

    Article  Google Scholar 

  88. Tarkan T, Turkeri L, Biren T, et al (1996) The effectiveness of imaging modalities in clinical staging of localized prostate carcinoma. Int Urol Nephrol 28:773–779

    Article  Google Scholar 

  89. Terris MK, McNeal JE, Freiha PS, et al (1993) Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol 149:1035–1039

    PubMed  CAS  Google Scholar 

  90. Thompson IM, Middleton RG, Optenberg SA, et al (1999) Have complication rates decreased after treatment for localized prostate cancer? J Urol 162:107–112

    Article  PubMed  CAS  Google Scholar 

  91. Vijayakumar VVijayakumar S, Quadri SF, et al (1994) Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer? Am J Clin Oncol 17:432–436

    Article  Google Scholar 

  92. Walsh PC. (1980) Radical prostatectomy for the treatment of localized prostate carcinoma. Urol Clin North Am 7:583–589

    PubMed  CAS  Google Scholar 

  93. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R (1999) The sentinel lymph node concept in prostate cancer-first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36:595–600

    Article  PubMed  CAS  Google Scholar 

  94. Zincke H, Utz DC, Myers RP, et al (1982) Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of the prostate with regional lymph node involvement. Urology 19:238–247

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Heidenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Wille
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. V. Knobloch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology and Pediatric Urology, Philipps Universität Marburg, Baldingerstrasse 3, 35043, Marburg/Lahn, Germany

    Reiner Hofmann  & Axel Heidenreich  & 

  2. Department of Surgery, USUHS, 430 I Jones Bridge Road, 20814-4799, Bethesda, MD, USA

    Judd W. Moul M.D. (Professor of Urology) (Professor of Urology)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hofmann, R., Heidenreich, A., Wille, S., Varga, Z., Knobloch, R.V. (2003). Preoperative Imaging Techniques in Prostate Cancer. In: Hofmann, R., Heidenreich, A., Moul, J.W. (eds) Prostate Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56321-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56321-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62643-2

  • Online ISBN: 978-3-642-56321-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation